| HS Code | 120234 |
| Density | 1.04 g/cm³ |
| Melting Point | 190 °C |
| Glass Transition Temperature | -45 °C |
| Tensile Strength At Yield | 28 MPa |
| Elongation At Break | >300% |
| Flexural Modulus | 500 MPa |
| Izod Impact Strength | No break |
| Shore Hardness | 63 Shore D |
| Water Absorption At Saturation | 1.6% |
| Water Absorption At 24h 23 C | 0.2% |
| Vicat Softening Temperature | 165 °C |
| Heat Deflection Temperature | 55 °C |
As an accredited Arkema Rilsan BESVO A MED PA11 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Arkema Rilsan BESVO A MED PA11 is supplied in 25 kg sealed bags, ensuring dry, contamination-free storage. |
| Container Loading (20′ FCL) | 20' FCL loading: palletized bags of Arkema Rilsan BESVO A MED PA11, secured, ventilated, moisture-protected for safe transport. |
| Shipping | Arkema Rilsan BESVO A MED PA11 is a medical-grade polyamide 11 powder shipped in sealed moisture-resistant containers. Transport at ambient temperature, protected from humidity, excessive heat, and direct sunlight. Handle with care to preserve integrity; non-hazardous, but avoid dust inhalation and follow standard safety data sheet procedures. |
| Storage | Store Rilsan BESVO A MED PA11 in its original, tightly sealed container in a cool, dry, well-ventilated area. Keep away from direct sunlight, heat sources, and high humidity, as PA11 can absorb moisture. Ideal storage temperature is below 30°C. Avoid contact with water and incompatible materials. Keep container closed when not in use. |
| Shelf Life | Shelf life: 2 years from manufacture if stored unopened, cool, dry, away from sunlight and moisture. |
Thin-wall single-lumen and multi-lumen catheter shafts are produced from Arkema Rilsan BESVO A MED PA11 on single-screw extruders equipped with 24:1 L/D barrier screws, 2.5:1 to 3.0:1 compression ratios, and 60/80/100 mesh screen packs. The resin is pre-dried to below 0.08% moisture by mass using desiccant air at -40°C dew point and 80°C for 4–6 h. Feed throat sections are blanketed with nitrogen because PA11 absorbs moisture rapidly from ambient air above 60% relative humidity. Barrel temperature profiles ascend from 230°C at the feed zone to 255–270°C in the metering zone. Die temperature is maintained at 260–275°C, and melt temperature at the die exit is measured by infrared pyrometry and limited to 280°C. A gear pump between screw tip and die reduces pressure pulsation. Without gear pump control, short-term output variation of ±1.5% produces wall-thickness scatter exceeding 0.04 mm at line speeds above 60 m/min.
Draw-down ratio is controlled between 1.5 and 3.0. Ratios above 3.0 increase axial orientation but also raise residual stress and produce ovality drift above 0.03 mm after 48 h at 23°C. Quench water temperature is held at 10–25°C with closed-loop agitation. Vacuum sizers with 0.05 mm incremental diameter inserts achieve outer diameter tolerances of ±0.05 mm. Post-extrusion annealing at 80°C for 4 h in nitrogen lowers locked-in orientation stress and stabilises dimensions before end-forming and tipping operations. The resulting catheter shaft products include peripheral intravenous catheter shafts, epidural catheter layers, and enteral feeding inner liners. Biological qualification references ISO 10555-1:2013 for intravascular catheters, ISO 10993-5:2009 for cytotoxicity, and ISO 10993-10:2010 for sensitisation.
Injection molding of male and female Luer components from BESVO A MED PA11 requires mold temperature control between 40°C and 60°C to suppress post-mold dimensional drift. Barrel temperature zones follow a profile from 230°C to 270°C, with injection pressures of 70–100 MPa and holding pressures of 50–80 MPa. Mold filling patterns are designed so that the weld line, when unavoidable, is positioned outside the sealing taper and the thread flank. Volumetric shrinkage in the flow direction is documented in the range 0.8–1.1% and transverse shrinkage 1.2–1.5% after 24 h at 23°C. Parts are therefore annealed at 80°C for 4 h before gauging. ISO 80369-7:2021 defines tapered Luer geometry, and dimensional acceptance is based on 6% taper pin gauges.
| Endpoint | Test method | Standard designation | Typical test condition |
|---|---|---|---|
| Cytotoxicity | Elution assay | ISO 10993-5:2009 | L-929 MEM extract, 37°C / 24 h |
| Sensitisation | Local lymph node assay / maximisation | ISO 10993-10:2010 | Repeated exposure, classification threshold |
| Irritation | Intracutaneous reactivity | ISO 10993-23:2021 | Normal saline and sesame oil extracts |
| Systemic toxicity | Acute systemic injection | ISO 10993-11:2017 | Single dose, 72 h observation |
| Chemical characterisation | GC-MS / LC-MS / ICP-MS extract screening | ISO 10993-18:2020 | Polar and non-polar extraction |
Ethylene oxide sterilisation per ISO 11135:2014 remains the preferred terminal treatment for Luer and stopcock components because the resin exhibits minimal change in melt flow rate after a standard cycle at 55°C and 600 mg/L EtO concentration. Post-irradiation residual stress cracking is a recognised failure mode when gamma dose exceeds 40 kGy without adequate mold-temperature annealing. The mechanism is solvolytic stress relaxation in the presence of residual internal tensile stress. Hot-runner valve gates reduce gate blush and lower the incidence of concentricity defects in male Luer bores. Regrind use requires documented process validation under ISO 13485:2016 and is commonly limited to 20% by mass unless revalidation of ISO 10993-18:2020 leachables demonstrates unchanged chemical characterisation.
Multilayer tubing constructs that pair BESVO A MED PA11 with maleic anhydride-grafted polypropylene or polyethylene tie layers are coextruded using barrier screw profiles with 24:1 L/D and spiral mandrel dies. The coextrusion die temperature is held at 250–270°C to maintain interfacial adhesion without causing tie-layer degradation. A documented viscosity mismatch above 1.3 between the PA11 melt and the tie resin at shear rates typical of coextrusion generates interfacial instabilities that appear as longitudinal weld lines in the inner lumen.
The low equilibrium moisture uptake of PA11 relative to short-chain aliphatic polyamides is operationally relevant in steam-sterilised multilayer structures. Per ISO 62:2008, PA11 saturation in water at 23°C is approximately 1.9% by mass, compared with 9.5% for PA6 and 1.3% for PA12. Lower swelling at the tie-layer interface reduces delamination risk after repeated 121°C steam cycles per ISO 17665-1:2006. This property directionally improves lumen collapse resistance in parenteral nutrition tubing where DEHP-free construction is a regulatory requirement under EU MDR 2017/745.
Tie-layer melt flow index is selected in the 2–6 g/10 min range at 190°C/2.16 kg per ISO 1133-1:2022 to maintain a viscosity ratio within 0.7–1.3 of the PA11 melt. Final tubing is post-extrusion annealed at 80°C for 4 h in nitrogen before spooling. End products include PVC-free intravenous infusion tubing, enteral feeding extension sets, and peristaltic pump segments. Compliance testing includes USP <88> Class VI, ISO 10993-5:2009, and ISO 10993-7:2008 for ethylene oxide residuals.
The answer lies in the hydrolytic scission of amide bonds during melt processing. Residual moisture above 0.08% by mass causes visible splay in sections thinner than 0.8 mm and produces microvoids that reduce yield consistency. BESVO A MED PA11 pellets are therefore dried in desiccant dryers supplied with -40°C dew point air at 80°C for 4–6 h, or in vacuum dryers at 80°C and 10 mbar for 8 h. Verification by Karl Fischer titration is performed on samples taken from the hopper after 2 h of drying.
The processing window for the melt is narrow. Melt temperature at the die exit is limited to 280°C. Excursions above 290°C accelerate carboxyl end-group formation and produce a measurable drop in solution viscosity per ISO 307:2019. Barrel residence time should not exceed 10 min. In thin-wall in-vitro diagnostic cartridge bodies and microfluidic housings molded from these resins, tool cavities are gated to balance flow and avoid dead zones that extend residence time. Published data for this specific grade configuration under thin-wall diagnostic geometries is limited. Process-capability studies are required to correlate end-group concentration with bond strength in solvent-bonded channels and burst integrity in pressure-sensitive assay chambers.
Cumulative steam sterilisation exposure is the dominant operational constraint when BESVO A MED PA11 replaces metal in reusable hand instruments. The resin can withstand 121°C for 15 min cycles per ISO 17665-1:2006 if parts are annealed at 80°C for 4 h in nitrogen after molding to relieve residual stress. Dry heat at 170°C for 60 min is not recommended. Oxidative discoloration and loss of notched Charpy impact per ISO 179-1:2023 are observed after repeated dry-heat cycles. Handling and cleaning agents should exclude quaternary ammonium concentrations above 2% because PA11 exhibits environmental stress cracking under combined load and surfactant exposure. Reusable forceps handle inserts, retractor grip sleeves, and instrument tray brackets are the primary downstream components. Published data for this specific configuration under repeated autoclave cycles is limited. Qualification under ISO 17665-1:2006 and ISO 13485:2016 must include dimensional inspection and extraction per ISO 10993-18:2020 after the maximum number of stated reuse cycles.
For single-use devices subjected to terminal sterilisation by radiation, dose mapping and material verification are indivisible. ISO 11137-1:2006 establishes dose-setting methods for gamma and electron beam processes. For plasticised PA11, absorbed gamma dose above 40 kGy can initiate chain scission that is measurable as an increase in melt flow rate per ISO 1133-1:2022 and a drop in elongation at break per ISO 527-2:2012. Gamma sterilisation at 25 kGy to 40 kGy is commonly used for PA11 medical devices. Published data for this specific grade configuration is limited. Functional testing after irradiation is mandatory because plasticiser-bearing PA11 can exhibit post-irradiation elongation retention that depends on antioxidant package and part cross-section.
| Method | Standard | Typical parameters | Observed effect on PA11 |
|---|---|---|---|
| Ethylene oxide | ISO 11135:2014 | 55°C, 600 mg/L, 6 h | Minimal mechanical shift; aeration required per ISO 10993-7:2008 |
| Gamma | ISO 11137-1:2006 | 25–40 kGy | Colour shift; mechanical retention depends on antioxidant and dose |
| Electron beam | ISO 11137-1:2006 | 25–40 kGy | High dose rate; localised radical density may alter surface hardness |
| Steam | ISO 17665-1:2006 | 121°C / 15 min | Dimensional relaxation possible; annealed parts required |
| Dry heat | ISO 20857:2010 | 170°C / 60 min | Not recommended; oxidative embrittlement risk |
Leachable evaluation after radiation should follow ISO 10993-18:2020 with extraction in polar and non-polar solvents. Plasticiser migration is assessed under ISO 10993-17:2023, and analytical evaluation thresholds are reported per extractable surface area. Devices exposed to 25 kGy gamma or electron beam should be conditioned at 23°C and 50% relative humidity for 24 h before destructive testing.
Auto-injector outer shells, dose-dial rings, and trigger sleeves are injection molded from BESVO A MED PA11 in multi-cavity hot-runner tools with sequential valve gating to suppress weld-line formation. Weld-line retention properties of PA11 are sensitive to mold temperature. Maintaining 60°C improves interflow healing and reduces visible knit lines in textured surfaces. Barrel temperatures follow the same profile used for Luer components, with injection speeds set to maintain shear rates below 30,000 s⁻¹ to avoid polymer degradation at the gate. Pressure-controlled transfer near the end of filling holds screw cushion at 2–4 mm and reduces part mass variation below 0.3%.
Sliding tolerance stacks in pen injectors benefit from the relatively low moisture absorption of PA11. Equilibrium moisture at 50% RH and 23°C is approximately 0.8% by mass per ISO 62:2008. This limits post-assembly swelling in humid patient environments and reduces binding in rotary dose-setting mechanisms. Dimensional capability is verified according to ISO 11608-1:2022 for needle-based injection systems, and chemical characterisation follows ISO 10993-18:2020. End products include insulin pen dose-click components, auto-injector trigger sleeves, and drug delivery device chassis inserts.
Competitive Arkema Rilsan BESVO A MED PA11 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Arkema Rilsan BESVO A MED PA11 is a bio-based polyamide 11 homopolymer produced from castor-oil-derived 11-aminoundecanoic acid. The grade is solid under normal ambient conditions and is supplied as cylindrical pellets for melt processing. The MED suffix identifies a raw-material qualification package aligned to specific biological evaluation endpoints; it does not signal a separate polymer backbone or a different melting point relative to general-purpose Rilsan PA11 extrusion grades. In thin-wall medical components such as luers, clips, catheter shafts, respiratory connectors, and imaging-equipment housings, the material is selected where a combination of low equilibrium moisture uptake, resistance to repeated hospital-grade disinfectants, and dry-as-molded dimensional stability is required. Devices manufactured from this grade must still undergo finished-device biological risk assessment under ISO 10993-1:2018, because the raw-material file does not eliminate the need for testing of the finished geometry, processing residuals, and packaging leachables.
The polyamide 11 repeat unit contains one amide group per 11 backbone carbon atoms. This spacing is larger than in polyamide 6 or polyamide 66, which present one amide group every 6 or 6 carbon atoms, respectively. The lower amide density reduces hydrogen-bonded water sorption. At 23 °C and 50% relative humidity, published PA11 conditioning data are generally below 1.5% moisture by mass, whereas PA6 can exceed 3.0%; at immersion saturation measured according to ISO 62:2008, PA11 values are approximately 1.8–1.9% while PA6 typically reaches 9–10%. The resulting hygroscopic expansion difference is significant for toleranced medical parts. A snap-fit or luer interface dimensioned at ±0.05 mm can be held more reliably through ambient humidity drift with PA11 than with PA6 or PA66. Published data for this specific BESVO A MED configuration is limited; lot-specific certificates of analysis should govern final release values.
Melt viscosity is influenced by batch-to-batch molecular weight distribution. Medical extruders running tight wall tolerances on multi-lumen tubing often implement incoming-lot capillary rheometry to set temperature offsets. A grade with a nominal melt volume-flow rate measured at 235 °C under 2.16 kg according to ISO 1133-1:2022 can shift by several units between production campaigns if packaging humidity has not been controlled. Rather than changing screw speed, the first corrective actions are verification of dryer dew point, pellet-bed depth, and feed-throat isolation.
The MED product line is supplied with documentation intended to reduce the regulatory burden for medical-device manufacturers. The documentation usually includes a statement of resin biocompatibility tests and raw-material change control. In many Arkema Rilsan MED product families, the base resin has been tested against ISO 10993-5:2009 for cytotoxicity, ISO 10993-10:2010 for irritation and delayed-type hypersensitivity, and USP <88> Class VI for systemic injection, intracutaneous reactivity, and implantation. The precise endpoints should be confirmed in the supplier's regulatory data sheet for the current lot.
This qualification does not alter the tensile strength at yield, flexural modulus, or Charpy impact response. The mechanical values are governed by molecular weight, plasticizer absence, and thermal history. For medical-device design, the practical effect of the MED suffix is that raw-material documentation can support ISO 14971 risk files and design-history-file inputs, but the device manufacturer must still classify the device contact duration, tissue type, and processing residuals according to ISO 10993-1:2018. Chronic implantation, blood contact, or drug-containing devices require additional endpoints from ISO 10993-4:2017, ISO 10993-6:2016, ISO 10993-11:2017, and ISO 10993-17:2023 where toxicological risk assessment is relevant. The BESVO A MED grade supports the material-selection phase; it cannot cover manufacturing aids, colorants, or process oils introduced downstream.
| Standard or method | Endpoint | Typical raw-material result | Remarks |
|---|---|---|---|
| ISO 10993-5:2009 | In vitro cytotoxicity | No significant cytotoxicity | MEM elution, 72 h |
| ISO 10993-10:2010 | Irritation and sensitization | No irritation or sensitization | Guinea pig maximization or LLNA depending on protocol |
| USP <88> Class VI | Systemic injection, intracutaneous, implantation | Pass | For materials with patient contact |
| ISO 10993-4:2017 | Hemocompatibility | Application-dependent | Required only for blood-contact claims |
| ISO 10993-11:2017 | Systemic toxicity | Application-dependent | Required for prolonged or permanent contact |
Water is the primary processing variable for polyamide 11. Pellets exposed to relative humidity above 60% must be dried before melt processing. Desiccant drying with an air dew point below -30 °C and a pellet-bed temperature of 80 °C for 4–6 h is standard for shallow single-layer streams; for cold-storage pallets or high-humidity warehouses, 8–12 h may be required. A residual moisture level below <0.1% by weight should be verified by a moisture analyzer before opening the feed hopper to atmospheric air. Drying-air hoppers with unheated feed throats can re-adsorb moisture rapidly in a climate-controlled molding room.
Extrusion melt temperatures for unplasticized PA11 are generally set between 200 °C and 250 °C. For thin-wall tubing, die temperatures near 230 °C are used. For injection molding, melt temperatures of 230–250 °C and mold temperatures of 40–70 °C are typical. Melt temperature above 270 °C or residence times exceeding 10 min increase oxidative and shear-induced chain scission. The melt-pressure signal should be monitored immediately before the breaker plate. On a production single-screw extruder with an L/D of 24:1 to 30:1, pressure variation greater than ±1.5% over 30 s commonly indicates residual moisture or feed segregation. Raising screw speed does not correct pressure variation caused by moisture; it can amplify hydrolytic degradation and reduce melt viscosity.
Screw selection for BESVO A MED in catheter shaft and multilayer extrusion should avoid high-shear general-purpose screws with compression ratios above 4.0:1 unless melt temperatures are reduced. A barrier-flighted screw with a compression ratio of 2.5:1 to 3.5:1 and a Maddock mixer in the metering zone provides dispersion without excessive shear heating. Capillary rheometry at shear rates from 50 s⁻¹ to 500 s⁻¹ and temperatures of 220 °C to 250 °C shows that polyamide 11 follows pseudoplastic behavior; apparent viscosity declines with increasing shear. This shear-thinning behavior supports thin-wall filling in multi-cavity tools but also means that gate speed and nozzle temperature must be matched to cavity pressure. Overly aggressive filling at low melt temperature can freeze orientation near the gate and produce anisotropic shrinkage; molders should monitor cavity-pressure curves and switch over at 90–95% of final cavity volume, with packing pressure limited to avoid flash.
Medical extrusion lines typically use melt filtration with mesh packs from 120 μm to 250 μm absolute to remove carbonized gels and incidental contamination. For BESVO A MED processed at 230 °C, screen-pack pressure rise should be recorded; a rapid rise greater than 2 MPa across the screen pack suggests contamination or thermal degradation. Breaker plates with 15–25% open area are common. This is not a substitute for clean-room material handling and lot traceability.
PA11 occupies a narrow processing-engineering niche. Compared with PA12, Rilsan BESVO A MED PA11 typically exhibits a higher melting peak near 189 °C by differential scanning calorimetry according to ISO 11357-3:2018, while PA12 melting peaks are nearer 178 °C. The higher crystalline melting temperature gives PA11 a higher modulus at elevated temperatures in dry environments. Compared with PA6 and PA66, the principal advantage is dimensional stability under humidity change rather than short-term strength. A dry-as-molded PA66 tensile yield may exceed PA11, but PA66 loses a larger fraction of room-temperature modulus after moisture uptake. When a design is validated at 23 °C and 50% relative humidity but shipped to a tropical environment, the lower equilibrium moisture uptake of PA11 reduces the shift in snap-fit insertion force and luer pull-out. Standard tensile testing should be performed according to ISO 527-2:2012 on dry and conditioned specimens.
A more useful design comparison is the change in linear dimension from dry-as-molded to equilibrium at 50% relative humidity. Published polyamide data indicates that PA6 and PA66 can exhibit linear changes of 0.7–1.0% under this condition, while PA11 typically exhibits less than 0.3%. This difference is not trivial in a 60 mm snap-fit span; it corresponds to a movement of approximately 0.6 mm for PA66 and 0.18 mm for PA11. The evaluation should be performed according to ISO 62:2008 with specimen measurement under controlled 23 °C and 50% relative humidity after drying to constant mass.
Compared with glassy polymers such as polycarbonate, PA11 is semicrystalline and less notch-sensitive at low temperature; its tensile modulus is lower, so load-bearing designs require ribs or thicker sections. The use of PA11 in fluid-contact fittings also benefits from stress-cracking resistance against lipid emulsions and high-pH cleaning agents. Compatibility should be verified by exposure testing according to ISO 22088-2:2006 or ASTM D543-20. In bellows, connectors, and manifolds exposed to quaternary ammonium disinfectants, citric-acid-based descalers, or peracetic acid sterilants, environmental stress-cracking should be evaluated under strain-dependent exposure because polyamides can crack under critical strain in the presence of certain aggressive agents. The material's susceptibility to acid hydrolysis at pH below 3 over repeated cycles is a relevant boundary condition; validation should include exposure to the most aggressive cleaning chemistry and maximum cumulative contact time.
The monomer is derived from castor oil; life-cycle assessment data and renewable-carbon documentation can be requested under ISO 14067 or ASTM D6866. This is a distinction from PA12, which is conventionally petroleum-based, and from PA6/PA66, which are also petroleum-derived. However, carbon footprint claims must be supported by the supplier's current life-cycle inventory and should not be used as a substitute for mechanical or biological qualification. Within the Rilsan PA11 portfolio, BESVO A MED differs from BESNO and BESVO non-medical grades primarily in the regulatory documentation and potential purity controls rather than in the backbone chemistry. Users should not interchange grades if the device-design history file is built on the MED lot-specific biological file; processability differences may still exist due to viscosity specification width and heat-stabilization packages. A direct replacement requires equivalence assessments according to the manufacturer's change-control procedure and relevant ISO 13485:2016 clauses.
| Property | Test method | Typical value | Condition |
|---|---|---|---|
| Density | ISO 1183-1:2019 | 1.03–1.04 g/cm³ | 23 °C |
| Melting temperature | ISO 11357-3:2018 | 189 °C | DSC, second heat, 10 K/min |
| Tensile strength at yield | ISO 527-2:2012 | 46–48 MPa | Dry as molded, 5 mm/min |
| Tensile strain at break | ISO 527-2:2012 | >50% | Dry as molded |
| Flexural modulus | ISO 178:2019 | 1,000–1,200 MPa | 23 °C, dry |
| Charpy notched impact strength | ISO 179-1:2010 | 6–8 kJ/m² | 23 °C, dry |
| Water absorption at saturation | ISO 62:2008 | 1.8–1.9% | 23 °C, immersion |
Operational limitations are primarily thermal, hygroscopic, and sterilization-related. The material must not be stored for extended periods in open containers under ambient conditions without drying-lot segregation. When relative humidity exceeds 60%, pellets should be dried to below 0.1% moisture before extrusion or molding. Avoid formulations containing amine-based additives unless the specific package has been solubility- and viscosity-tested, because amines can catalyze amide interchange and shift the molecular weight distribution. The polymer is not inherently radiopaque for catheter and introducer applications; radiopaque formulations must be evaluated for particle-size distribution, dispersion consistency, and biological endpoints before use.
Steam sterilization at 121 °C can be used for limited-cycle devices, but cumulative hydrolytic degradation should be measured as the percentage retention of tensile elongation at break after the maximum validated cycle count. Gamma irradiation at 25–50 kGy is commonly applied to polyamide 11 medical components; however, published data for this specific configuration under all dose rates and packaging residuals is limited, and final-device qualification must address color shift, volatile residues, and extractables under ISO 10993-7:2008 and ISO 10993-12:2021. Ethylene oxide sterilization is also used; because polyamides can retain low levels of residuals, aeration time should be validated by gas chromatography against the residue limits of ISO 10993-7:2008.